Fate Therapeutics
FATEAlgoritmens signaler
- ›Starkt 3m-momentum (+93.5%)
- ›Starkt 6m-momentum (+91.7%)
- ›Starkt 12m-momentum (+75.6%)
- ›Pris över MA50 och MA200 (uppåttrend)
- ›Hög volatilitet (117% årlig)
- ›+130% från 52v-botten
- ›Ökad handelsvolym (+72%)
📰 Senaste nyheter & analys
Källor: Placera, Nyhetsbyrån Direkt, Google NewsFate Therapeutics Inc (FATE) Institutional Confidence - TradingKey
13 h sedanFate Therapeutics Inc (FATE) Institutional Confidence TradingKey
TradingKeyFate Therapeutics Inc (FATE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
14 h sedanFate Therapeutics Inc (FATE) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey
TradingKeyDirector Laura Hamill files initial Form 3 for FATE Therapeutics (FATE) - Stock Titan
3 d sedanDirector Laura Hamill files initial Form 3 for FATE Therapeutics (FATE) Stock Titan
Stock TitanFate Therapeutics Showcases Data from FT819 and FT839 - GlobeNewswire
2026-06-04Fate Therapeutics Showcases Data from FT819 and FT839 GlobeNewswire
GlobeNewswireWill Fate Therapeutics (NASDAQ:FATE) Spend Its Cash Wisely? - Yahoo Finance
2026-05-30Will Fate Therapeutics (NASDAQ:FATE) Spend Its Cash Wisely? Yahoo Finance
Yahoo FinanceH.C. Wainwright raises Fate Therapeutics price target to $7 on SLE data - Investing.com
2026-05-04H.C. Wainwright raises Fate Therapeutics price target to $7 on SLE data Investing.com
Investing.comGreat week for Fate Therapeutics, Inc. (NASDAQ:FATE) institutional investors after losing 6.3% over the previous year - simplywall.st
2026-01-17Great week for Fate Therapeutics, Inc. (NASDAQ:FATE) institutional investors after losing 6.3% over the previous year simplywall.st
simplywall.stCompanies Like Fate Therapeutics (NASDAQ:FATE) Could Be Quite Risky - Yahoo Finance
2025-12-21Companies Like Fate Therapeutics (NASDAQ:FATE) Could Be Quite Risky Yahoo Finance
Yahoo FinanceFATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm
2024-06-13FATE SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Fate Therapeutics, Inc. (NASDAQ: FATE) and Encourages Long-Term FATE Investors to Contact the Firm PR Newswire PHILADELPHIA, June 13,
Fate TherapeuticsPR NewswireFATE THERAPEUTICS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fate Therapeutics, Inc. - FATE
2023-07-01Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Fate Therapeutics,
Fate TherapeuticsBusinesswireFATE THERAPEUTICS ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2023-06-22Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fate Therapeutics, Inc. (NASDAQ: FATE) on behalf of long-term stockholders f
Fate TherapeuticsBusinesswireFate ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
2023-06-09Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Fate Therapeutics, Inc. (NASDAQ: FATE) on behalf of long-term stockholders f
Fate TherapeuticsBusinesswireFINAL DEADLINE TODAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Fate Therapeutics, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important March 22 Deadline in Securities Class Action – FATE
2023-03-22WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Fate Therapeutics, Inc. (NASDAQ: FATE) between April 2, 2020 and January 5, 2023, both dates inclusive (
Fate Therapeutics IncBusinesswireSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE)
2023-03-22SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Fate Therapeutics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 22, 2023 - (NASDAQ: FATE) PR Newswire NEW YORK,
Fate TherapeuticsPR NewswireFATE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc. and Encourages Investors to Contact the Firm
2023-03-22Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Fate Therapeutics, Inc. (“Fate” or the “Company”)
Fate Therapeutics IncBusinesswireThe Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Fate Therapeutics, Inc. (FATE)
2023-03-21The Law Offices of Frank R. Cruz reminds investors of the upcoming March 22, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Fate Therapeuti
Fate Therapeutics IncBusinesswire
Klicket på "Köp i Nordnet" öppnar din Nordnet-app om installerad — där loggar du in med BankID. Annars öppnas Nordnets webbsajt där du kan logga in med BankID på samma sätt.